Tag: NASDAQ:MACK

Gilead Sciences GILD NASDAQ:GILD
Finance

Biotech GAiners: BioCryst Pharmaceuticals (NASDAQ:BCRX), Dyax Corp. (NASDAQ:DYAX), Novavax, Inc. (NASDAQ:NVAX), Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares closed up nearly 11% on Tuesday after the company reported positive data from its OPuS-1 mid-stage study involving BCX4161 as a treatment for hereditary angioedema, or HAE. This is a rare immune disorder that can cause swelling of the face, breathing airways, and also causes abdominal cramping. According to the preliminary results from the company’s proof-of-concept study, BCX4161 met both … Continue reading Biotech GAiners: BioCryst Pharmaceuticals (NASDAQ:BCRX), Dyax Corp. (NASDAQ:DYAX), Novavax, Inc. (NASDAQ:NVAX), Merrimack Pharmaceuticals Inc (NASDAQ:MACK)

Kevin Long
Finance

Volatile Stocks: MeetMe Inc (NASDAQ:MEET), Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Pernix Therapeutics Holdings Inc (NASDAQ:PTX), Dillard’s (NYSE:DDS), Just Energy Group (NYSE:JE)

MeetMe Inc (NASDAQ:MEET), the public market leader for social discovery, has released Icebreakers, a new feature for the MeetMe iPhone app that makes it easier for users to start a chat. “Icebreakers solves the problem of the empty chat screen,” said Geoff Cook, CEO of MeetMe. “Rather than starting conversations with a generic ‘Hi’ or ‘What’s up,’ or possibly not starting them at all for … Continue reading Volatile Stocks: MeetMe Inc (NASDAQ:MEET), Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Pernix Therapeutics Holdings Inc (NASDAQ:PTX), Dillard’s (NYSE:DDS), Just Energy Group (NYSE:JE)

Kristen Barton
Finance

Recent Insider Buying: AOL, Inc. (NYSE:AOL), Tyco International Ltd. (NYSE:TYC), Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Emerson Electric Co. (NYSE:EMR)

AOL Inc (NYSE:AOL) CEO Timothy M. Armstrong purchased 55,600 shares of AOL Inc (NYSE:AOL) stock in a transaction that occurred on Thursday, May 8th. The stock was purchased at an average cost of $36.08 per share, for a total transaction of $2,006,048.00. AOL, Inc. (NYSE:AOL) stock performance was 3.71% in last session and finished the day at $37.74. Traded volume was 3.27million shares in the … Continue reading Recent Insider Buying: AOL, Inc. (NYSE:AOL), Tyco International Ltd. (NYSE:TYC), Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Emerson Electric Co. (NYSE:EMR)

Jason Knox
Finance

NASDAQ Losers: ON Semiconductor Corp (NASDAQ:ONNN), Endocyte (NASDAQ:ECYT), Actuate Corp (NASDAQ:BIRT), Merrimack Pharmaceuticals (NASDAQ:MACK)

ON Semiconductor Corp (NASDAQ:ONNN)’s adjusted earnings totaled $75.2 million, or 17 cents a share, while revenue increased year over year to $706.5 million from $661 million. Analysts polled by Thomson Reuters expected the company to earn 15 cents a share on revenue of $711.67 million. The company issued second-quarter revenue guidance in the range of $738 million to $768 million. ON Semiconductor Corp (NASDAQ:ONNN) stock … Continue reading NASDAQ Losers: ON Semiconductor Corp (NASDAQ:ONNN), Endocyte (NASDAQ:ECYT), Actuate Corp (NASDAQ:BIRT), Merrimack Pharmaceuticals (NASDAQ:MACK)

Colin Pettis
Finance

Biotech Bullish Stocks: Merrimack Pharmaceuticals (NASDAQ:MACK), Sarepta Therapeutics (NASDAQ:SRPT), Northwest Biotherapeutics (NASDAQ:NWBO), Progenics Pharmaceuticals (NASDAQ:PGNX)

Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) announced that it will present at the 2014 AACR Annual Meeting. The conference will take place on April 5-9, 2014 at the San Diego Convention Center in San Diego. Presentations will include a clinical pilot study evaluating the feasibility of using ferumoxytol* as an MRI imaging agent prior to MM-398 investigational treatment. Merrimack Pharmaceuticals Inc (NASDAQ:MACK) stock performance was 6.15% in … Continue reading Biotech Bullish Stocks: Merrimack Pharmaceuticals (NASDAQ:MACK), Sarepta Therapeutics (NASDAQ:SRPT), Northwest Biotherapeutics (NASDAQ:NWBO), Progenics Pharmaceuticals (NASDAQ:PGNX)

Mark DeFrance
Finance

Healthcare Unusual Volume: Palatin Technologies (NYSEMKT:PTN), AVEO Pharmaceuticals (NASDAQ:AVEO), Aastrom Biosciences (NASDAQ:ASTM), Merrimack Pharmaceuticals (NASDAQ:MACK)

Palatin Technologies (NYSE:PTN) major shareholder Bvf Partners L. P/Il sold 540,181 shares of Palatin Technologies stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $1.14, for a total transaction of $615,806.34. Palatin Technologies, Inc. (NYSEMKT:PTN) stock performance was 17.07% in last session and finished the day at $1.44. Traded volume was 3.33 million shares in the last … Continue reading Healthcare Unusual Volume: Palatin Technologies (NYSEMKT:PTN), AVEO Pharmaceuticals (NASDAQ:AVEO), Aastrom Biosciences (NASDAQ:ASTM), Merrimack Pharmaceuticals (NASDAQ:MACK)

Jayne Crisman